Why the study?
Does high-dose nitroglycerin combined with BiPAP improve respiratory failure and prevent intubation in patients with sympathetic crashing acute pulmonary edema?
Does high-dose nitroglycerin combined with BiPAP improve respiratory failure and prevent intubation in patients with sympathetic crashing acute pulmonary edema?
High-dose intravenous nitroglycerin combined with BiPAP rapidly resolves respiratory failure and prevents intubation in patients with sympathetic crashing acute pulmonary edema (SCAPE).
Answers are grounded in this paper and cite their sources.
Case reports suggest high-dose nitroglycerin plus BiPAP may avoid intubation in SCAPE; hypothesis-generating and should not change practice.
Acute pulmonary edema due to sympathetic surge and increased peripheral vascular resistance often present to the emergency department (ED) with markedly elevated blood pressure, severe dyspnea, and desaturation. This condition is known as "SCAPE" (sympathetic crashing acute pulmonary edema). We present three SCAPE patients who were successfully treated with high-dose nitroglycerin (NTG) and bilevel positive airway pressure (BiPAP) ventilation. All three patients presented with respiratory failure on arrival but rapidly improved after treatment and did not require endotracheal intubation or admission to the intensive care unit (ICU). SCAPE patients usually present to the ED with extreme respiratory distress associated with diaphoresis, restlessness, and high blood pressure. Emergency physicians must know how to manage SCAPE with high-dose nitrates and NIPPV (noninvasive positive pressure ventilation) because, when treated promptly, one will not only save a life but also obviate the need for endotracheal intubation and ICU admission.
No takes yet. Share an insight, caveat, or question.
Hsieh et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: